flufenamic acid has been researched along with Osteoporosis in 2 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X | 1 |
| Li, Z | 1 |
| Liu, H | 1 |
| Zhu, Y | 1 |
| Xia, D | 1 |
| Wang, S | 1 |
| Gu, R | 1 |
| Wu, W | 1 |
| Zhang, P | 1 |
| Liu, Y | 1 |
| Zhou, Y | 1 |
| Pietrogrande, V | 1 |
| Peretti, G | 1 |
| Torri, G | 1 |
2 other studies available for flufenamic acid and Osteoporosis
| Article | Year |
|---|---|
Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway.
Topics: Animals; Bone and Bones; Cell Differentiation; Cells, Cultured; Female; Flufenamic Acid; Humans; Mes | 2019 |
[Use of a drug combining flufenamic acid and several vitamins in orthopedics and traumatology].
Topics: Adult; Arthritis; Contusions; Drug Combinations; Female; Flufenamic Acid; Fractures, Bone; Humans; J | 1974 |